+1(312)-985-6461
We offer cutting-edge amniotic skin substitutes developed from donated placental tissue, promoting healing for non-healing wounds such as diabetic foot ulcers and venous leg ulcers.
At its core, our amniotic skin substitutes represent the future of wound healing. Sourced from donated placental tissue following healthy, full-term births, these advanced grafts are engineered to accelerate recovery in chronic, non-healing wounds. Whether treating diabetic foot ulcers, venous leg ulcers, or pressure injuries, our products offer biological support to stimulate tissue regeneration and reduce inflammation. Backed by science and trusted by providers nationwide, they’re reshaping outcomes for patients who previously had few effective options.
Biological Healing:
Our grafts are rich in growth factors, cytokines, and ECM proteins—designed to activate the body’s natural healing mechanisms and shorten recovery time.
Ethically Sourced:
Collected with full donor consent after healthy deliveries, each tissue product undergoes rigorous screening and processing to ensure safety and effectiveness.
CMS-Recognized:
Our skin substitutes are listed on the ASP index, making them eligible for Medicare reimbursement and ideal for clinics and facilities serving chronic wound populations.
Easy Application:
Delivered in ready-to-use formats that integrate seamlessly into your care protocol—no complex storage or preparation required.
In today’s wound care landscape, access to advanced healing shouldn’t come with complexity or compromise. At WoundMatrix, we simplify the entire process—from product selection and eligibility to delivery and billing—so your team can stay focused on care. With one of the widest selections of CMS-approved amniotic grafts, personalized support, and nationwide reach, we empower providers with tools that truly change lives. Experience the difference of wound care done right—built for outcomes, backed by integrity, and delivered with precision.